C.I. MEDICAL, 63% Increase in Ordinary Profit for The Current Fiscal Year

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Wed Feb 12, 2025 3:30 pm JST Earnings

3540 C.I. MEDICAL CO.,LTD. 【J-GAAP】

Earnings Report

C.I. MEDICAL CO.,LTD. <3540> [TSE Std] announced its financial results after the market closed on February 12th (15:30). The consolidated ordinary profit for the fiscal year ending December 2024 decreased 20.5% from the previous period to 2.62 billion yen. In the fiscal year ending December 2025, the profit is expected to expand to 62.8% to 4.26 billion yen. This will be the thirteenth consecutive term of revenue growth.

At the same time, the company decided to implement a year-end dividend of 12.53 yen for the previous term, which had been previously undecided, and has left the annual dividend for the current term undetermined.

In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit surged 2.5 times that of the same period last year, reaching 1.33 billion yen. The operating profit margin improved from 3.7% in the same period last year to 6.2%.

Kabutan News

Actual Results

Historical Performance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2022	42,891	3,990	3,889	2,521	50.4	5.04	Feb 14, 2023	J-GAAP
Dec, 2023	45,628	2,989	3,295	2,082	41.7	5.04	Feb 13, 2024	J-GAAP
Dec, 2024	67,493	2,493	2,621	6,266	125.3	12.53	Feb 12, 2025	J-GAAP
YoY	+47.9%	-16.6%	-20.5%	+201.0%	+200.9%

Full Year Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2024 Guidance	67,553	2,349	2,475	6,130	122.6	－	Nov 7, 2024	J-GAAP
Dec, 2024 Results	67,493	2,493	2,621	6,266	125.3	12.53	Feb 12, 2025	J-GAAP
Revision Rate	-0.1%	+6.1%	+5.9%	+2.2%	+2.2%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan - Jun, 2024	24,316	983	971	577	11.6	0	Aug 13, 2024	J-GAAP
Jan - Jun, 2025 Guidance	46,114	1,842	1,917	1,598	32.0	－	Feb 12, 2025	J-GAAP
YoY	+89.6%	+87.4%	+97.4%	+176.9%	+176.7%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2023	45,628	2,989	3,295	2,082	41.7	5.04	Feb 13, 2024	J-GAAP
Dec, 2024	67,493	2,493	2,621	6,266	125.3	12.53	Feb 12, 2025	J-GAAP
Dec, 2025 Guidance	95,000	4,135	4,268	3,128	62.6	－	Feb 12, 2025	J-GAAP
YoY	+40.8%	+65.9%	+62.8%	-50.1%	-50.1%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	11,980	441	543	343	6.9	3.7	Feb 13, 2024	J-GAAP
Jan - Mar, 2024	11,946	407	407	247	5.0	3.4	May 14, 2024	J-GAAP
Apr - Jun, 2024	12,370	576	564	330	6.6	4.7	Aug 13, 2024	J-GAAP
Jul - Sep, 2024	20,932	125	314	4,760	95.2	0.6	Nov 12, 2024	J-GAAP
Oct - Dec, 2024	22,245	1,385	1,336	929	18.6	6.2	Feb 12, 2025	J-GAAP
YoY	+85.7%	+214.1%	+146.0%	+170.8%	+170.8%